Be the first to like this
Rick Connell, Vice President and
Worldwide Head of External Research
Solutions, Pfizer Global research & Development, moderates an expert panel discussion around the emerging realm of risk share in drug discovery, and speaks with Mark Ashton, Executive Vice President of Business Development, Evotec, Bill Farley, Vice President of Business Development, ChemDiv, and Sri Mosur,
CEO and President, Jubilant Discovery Services.